Verified peer comparison
XWELL vs DiaMedica Therapeutics Financial Comparison
Direct answer
XWELL and DiaMedica Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free XWELL email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- XWELL Revenue
- 29,210,000 USD
- DiaMedica Therapeutics Revenue
- 0 USD
- XWELL Operating income
- -9,356,000 USD
- DiaMedica Therapeutics Operating income
- -34,397,000 USD